Quality Systems
Quality Systems Must Face Lawsuit Accusing Management of Insider Trading and Defrauding Investors According to a filed securities class action complaint, Quality Systems (QSII) flaunted substantial sales growth and an
Quality Systems Must Face Lawsuit Accusing Management of Insider Trading and Defrauding Investors According to a filed securities class action complaint, Quality Systems (QSII) flaunted substantial sales growth and an
Tableau Accused of Downplaying Competitive Threats Purchasers of Tableau Software, Inc. (DATA) filed a securities class action complaint against the company’s officers and directors for alleged violations of the Securities
Meridian Subsidiary is Under Investigation for Inaccurate Lead Tests Investors of Meridian (NasdaqGS: VIVO) filed a securities class action complaint against the company’s officers and directors for alleged violations of
INC Research Accused of Misleading Investors About Its Merger On August 1, 2017, INC announced that it merged with inVentiv Health, Inc., representing the merger as “the beginning of an
OSI Systems Accused of Obtaining Major Contract Through Corruption According to the complaint, on August 21, 2013, OSI (NasdaqGS: OSIS) announced that it had entered into a 15-year agreement to
Banc of California Accused of Engaging in Sham Accounting Practices A former employee of Banc of California (NYSE: BANC) has sued the company for wrongful retaliation and has accused it
GlobalSCAPE Accused of Overstating Its Financial Figures According to a class action complaint filed against GlobalSCAPE (GSB), Global officials assured investors of the effectiveness of the company’s internal control over
Investigation into Officers and Directors of Eagle Bancorp, Inc. December 13, 2017 (San Diego, CA & Bethesda, MD) – Shareholder rights law firm Robbins LLP is investigating whether certain officers
Ophthotech Corporation Accused of Misrepresenting Approval Capacity of Its Drug Investors of Ophthotech Corporation (OPHT) filed a securities class action complaint against the company’s officers and directors for alleged violations of
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.